Login / Signup

First Evaluation Switching From Ropivacaine to Highly Concentrated Bupivacaine in Intrathecal Mixtures for Cancer Pain.

Florent BienfaitSabrina Jubier-HamonValérie SeegersYves-Marie PluchonNathalie LebrecVirginie JaoulFrançois BoréThierry DelormeJulien RobertMartine BellangerJérémy SorrieulDenis Dupoiron
Published in: Neuromodulation : journal of the International Neuromodulation Society (2021)
Switching from ropivacaine to bupivacaine in IDDS appears more efficacious while remaining just as secure, and at lower cost.
Keyphrases
  • postoperative pain
  • pain management
  • papillary thyroid
  • squamous cell
  • chronic pain
  • ionic liquid
  • squamous cell carcinoma
  • lymph node metastasis
  • neuropathic pain
  • childhood cancer
  • spinal cord injury